Should a Struggling Medtech Company Get a Second Chance: Interview With IONIQ CEO Jared Bauer
October 28, 2021
IONIQ CEO, Jared Bauer – a self-described “heavy thinker” was featured in a recent episode of Medsider.
Bauer explains the two key factors he looks at when determining whether a medical device company is worth trying to turn around, why finding investors who really care about your mission is a strategic benefit, and why he hopes that IONIQ’s devices will one day have a place in your medicine cabinet.
IONIQ Sciences, using bioimpedance, is developing a device that can potentially detect cancers in early stages. The company’s device was granted a breakthrough designation for lung cancer by the FDA in 2020.
Recent News
- Canyon Labs Launches Expanded Reprocessing Validation Services for Medical Devices
- Connecting with Life Sciences in Logan
- Halia Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
- Ratio Therapeutics Enters into Research Collaboration, License Agreement with RayzeBio to Advance a Novel Radiopharmaceutical Program
- Co-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in Florida
- Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India
